Comparison
Ablepharon Macrostomia Syndrome C1860224 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between Ablepharon Macrostomia Syndrome and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
Ablepharon Macrostomia Syndrome C1860224
A rare genetic disorder affecting facial development, causing absent or underdeveloped eyelids and an unusually wide mouth. Requires specialized surgical and medical care.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
Ablepharon Macrostomia Syndrome C1860224
Variable
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
Ablepharon Macrostomia Syndrome C1860224
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
Ablepharon Macrostomia Syndrome C1860224
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
Ablepharon Macrostomia Syndrome C1860224
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
Ablepharon Macrostomia Syndrome C1860224
congenital
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
Ablepharon Macrostomia Syndrome C1860224
rare-disease
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
ablepharon-macrostomia-syndrome-C1860224 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Ablepharon Macrostomia Syndrome C1860224 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Eyelid development | Absent or underdeveloped eyelids are described. | Eyelid abnormalities are not established by the supplied data. | High |
| Mouth width | An unusually wide mouth is described. | A wide mouth is not established by the supplied data. | High |
| Development and kidneys | Developmental delay or kidney disease is not established here. | Developmental delays, neurological features, and possible kidney involvement are described. | Moderate |
When to favor each condition
Choose Ablepharon Macrostomia Syndrome C1860224 when
Prominent eyelid and mouth findings
These facial features match the supplied description of ablepharon-macrostomia syndrome.
Moderate
Need for specialized facial care
The source states that specialized surgical and medical care is required.
Moderate
Severe congenital presentation
The supplied severity is severe, although diagnosis still needs clinician confirmation.
Low
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
Developmental or neurological concerns
These features are described for 17q12 recurrent deletion syndrome.
Moderate
Possible kidney involvement
The source specifically notes potential kidney involvement requiring monitoring.
Moderate
Suspected chromosome 17 deletion
The condition is defined by a deletion on chromosome 17, confirmed by appropriate genetic testing.
High
How key tests differ
| Test | Ablepharon Macrostomia Syndrome C1860224 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Clinical examination | Facial findings, especially eyelids and mouth, are central. | Developmental, neurological, and possible renal clues may be sought. | Examination guides suspicion but does not establish either diagnosis alone. |
| Genetic testing | A genetic cause is stated, but the exact test result is not supplied. | Testing may identify a recurrent deletion on chromosome 17. | Genetic confirmation should be interpreted by a qualified clinician or genetics service. |
| Kidney assessment | Kidney abnormalities are not established by the supplied data. | Monitoring is appropriate because kidney involvement is possible. | An abnormal renal result is a finding, not by itself a syndrome diagnosis. |
Prognosis comparison
Ablepharon Macrostomia Syndrome C1860224
- Outcome
- A severe chronic course is indicated, but specific outcomes are not established.
- Factors
- Facial findings and need for specialized care may influence management.
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- A moderate chronic course is indicated, with variable features not quantified here.
- Factors
- Developmental, neurological, and possible kidney involvement may affect follow-up.
Time frame: Onset is variable for the left condition; right-sided onset is not established.
Prognosis should be individualized because mortality, prevalence, and long-term outcomes are not supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Eye protection | Underdeveloped eyelids may create a need for specialized eye care. Eye complications are not established here. Specific risks and procedures are not supplied and require specialist assessment. |
| Developmental needs | Developmental complications are not established by the source. Developmental delays and neurological features may require support. The range and severity are not quantified in the supplied data. |
| Kidney complications | Renal complications are not established here. Potential kidney involvement warrants regular monitoring. No cutoff, prevalence, or outcome is provided. |
Patient education highlights
- HighDiagnosis confirmation
These descriptions do not replace genetic evaluation or clinician interpretation.
- HighCare planning
Left-sided care may emphasize facial and surgical needs; right-sided care emphasizes monitoring and supportive therapies.
- MediumInheritance and transmission
Neither condition is communicable. Genetic counseling can address inheritance questions not resolved here.